BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Phase I (World)
Critical Pharmaceuticals Limited, The University of Nottingham And Nottingham University Hospitals NHS Trust Starts First Phase I Clinical Trial On A Nano-Enabled Intranasal Teriparatide For The Treatment Of Osteoporosis 4/15/2014  More...
Vectura Group plc (VEC.L): FAVOLIR Regulatory Update 4/11/2014  More...
Prothena Corporation plc Release: First Human Dosed In Phase 1 Study Of PRX002 For Treatment Of Parkinson's Disease 4/9/2014  More...
Newron Pharmaceuticals (NWRN) Release: New Results With NW-3509 Presented At SIRS Conference 4/8/2014  More...
Oxford BioMedica PLC (OXB.L) Completes Patient Recruitment Into Retinostat® Phase I Trial 4/7/2014  More...
Novartis AG (NVS) Shows Off A Strong Pipeline Of 19 New Compounds At American Association for Cancer Research 4/4/2014  More...
Kamada Ltd. (KMDA.TA) Announces U.S. Proof-Of-Concept Study With Glassia® For Graft-Versus-Host Disease 4/3/2014  More...
Novaliq GmbH Announces Launch Of A Phase 1 Study Following US And European Patent Approval Of Cyclasol® (Cyclosporin) Eye Drops 4/3/2014  More...
Innate Pharma (IPH.PA ) : Start Of Cohort Expansion Of Phase I Trial With Lirilumab And Nivolumab In Selected Solid Tumors 3/31/2014  More...
e-Therapeutics plc Reports Positive Interim Results From UK Phase Ia Trial Of ETS2101 (Dexanabinol) In A Variety Of Solid Tumours 3/31/2014  More...
Ability Pharmaceuticals Initiates Clinical Trial With Its Dual mTORC1/C2 Inhibitor ABTL0812 In Patients With Lung And Pancreatic Cancer 3/26/2014  More...
Scancell: 8mg Higher Dose SCIB1 Study On Track 3/21/2014  More...
Adocia Confirms Positive Clinical Results For Its Biochaperone® Combo, A Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro 3/20/2014  More...
Hua Medicine Reports Strong Results For Early Diabetes Drug Trial 3/20/2014  More...
GW Pharmaceuticals Provides Update on Cannabinoid Pipeline 3/17/2014  More...
Betagenon AB: First Time In Man-AMPK Activator O304 3/10/2014  More...
Adocia Announces Preliminary Positive Clinical Results For Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Analog Lispro, Biochaperone® Combo 2/27/2014  More...
GANYMED Pharmaceuticals AG's IMAB027 Enters Phase I/II Clinical Trial For Ovarian Cancer 2/12/2014  More...
Nanobiotix: Sees Clinical Advance In Soft Tissue Sarcoma Pilot Trial With Lead Product, NBTXR3 Market Development Plan Outlined For Earlier Potential Launch In 2016 2/11/2014  More...
THERAVECTYS Finalizes The Recruitment Of Patients For The Phase I/II Clinical Trial Of Its Anti-HIV Therapeutic Vaccine Candidate 2/5/2014  More...
Bionomics Limited (BMICY.PK) Release: BNC105 Phase I/II Trial Achieves A High Response Rate In Ovarian Cancer 2/3/2014  More...
Admedus Herpes Interim Phase I Results 2/3/2014  More...
Orion Corporation Release: The Androgen Receptor Inhibitor ODM-201 - New Insights In The Treatment Of Prostate Cancer 2/3/2014  More...
e-Therapeutics plc Temporary Halts Recruitment Into ETS2101 Cancer Trials 1/24/2014  More...
Pluristem Therapeutics (PSTI)' Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints 1/21/2014  More...
Faron Pharmaceuticals Release: Promising New Treatment For Life Threatening Acute Respiratory Distress Syndrome (ARDS) 1/15/2014  More...
Oxford BioMedica PLC (OXB.L) Announces Publication Of ProSavin® Phase I/II Study in The Lancet 1/10/2014  More...
BrainStorm Cell Therapeutics Inc. Says Stem Cells Helped 75-Year Old Patient With ALS And MG 1/7/2014  More...
Results Of Pluristem Therapeutics (PSTI)'s Phase 1/2 Muscle Injury Trial To Be Announced On January 21, 2014 1/6/2014  More...
ARTES Biotechnology Release: TA101 GOCLIN European Funded Project For The Development Of An Innovative Product For The Treatment Of Rheumatoid Arthritis – 1,7M€ Total Budget 12/23/2013  More...
Blaze Bioscience Inc. Announces Initiation Of First-In-Human Phase 1 Clinical Study Of BLZ-100 12/19/2013  More...
BeiGene Co.,Ltd Enrolls First Patient In Phase 1 Study Of BGB-283 12/19/2013  More...
BioLineRx Ltd. Enters Clinic With Novel Treatment For Celiac Disease 12/19/2013  More...
BerGenBio AS Release: Data Highlights BGB324 As A Potential Novel Treatment Option For Drug Resistant Chronic Myeloid Leukemia 12/17/2013  More...
Drawbridge Pharmaceuticals Initiates Clinical Trial For Phaxan™ 12/16/2013  More...
CureVac GmbH Completes Patient Recruitment For Phase 2 Clinical Trial Of Mrna-Based Prostate Cancer Treatment 12/16/2013  More...
MorphoSys AG Announces Additional Clinical Trial of MOR208 12/10/2013  More...
Adaptimmune Ltd. Announces Interim Results From A Phase I/II Trial Of Engineered T Cells Targeting Cancer Testis Antigens In Multiple Myeloma 12/10/2013  More...
Summit Corporation Announces First Patient Dosed In A Phase 1b Clinical Trial Of Smt C1100 For Treatment Of Duchenne Muscular Dystrophy 12/9/2013  More...
Rhizen Pharmaceuticals S.A. Announces Initiation Of A "First In Human" Phase-1 Trial Of RP6530, A Dual PI3K Delta/Gamma Inhibitor, In Patients With Hematological Malignancies 12/6/2013  More...
Anti-Cancer Program Originating From Lead Discovery Center Reaches Clinical Trials 12/5/2013  More...
Galapagos NV (GLPG.BR) Reports Positive Phase 1 Results For GLPG1205 12/4/2013  More...
VBL Therapeutics Receives FDA Fast Track Designation For Lead Compound VB-111 11/27/2013  More...
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 1 Study Of ISIS-GSK3 Rx And Earns $3 Million Milestone Payment From GlaxoSmithKline (GSK) 11/26/2013  More...
Living Cell Technologies Ltd. Release: NTCELL Clinical Trial: Recruitment Of Further Patients Approved 11/25/2013  More...
TopoTarget A/S Release: Final Results From CLN-14 Study In STS 11/20/2013  More...
BioLineRx Ltd. Reports Publication In Peer Review Journal Of Positive Phase 1/2 Results In Stem Cell Mobilization For Multiple Myeloma 11/19/2013  More...
Adocia Announces The Initiation Of A Clinical Trial On Its Combination Of The Long-Acting Insulin Glargine And A Fast-Acting Insulin Analog 11/13/2013  More...
PROMETHERA Biosciences S.A./N.V. Successfully Enrols Twenty Patients In Its Multicentric Phase I/II Trial 11/12/2013  More...
Gentium S.p.A. Announces Successful Completion Of Defibrotide Phase 1 Study In Japan 11/12/2013  More...
GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM) -Study Features THC and CBD as the Primary Cannabinoids 11/11/2013  More...
FDA Grants Orphan Drug Status for PAT-SM6 11/6/2013  More...
Swedish Orphan Biovitrum Hosts Capital Market Day Event - Announces Phase I Complement Inhibitor Programs 11/5/2013  More...
Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 11/4/2013  More...
SEEK Announces Publication of HIV-v Data in Vaccine Journal 11/1/2013  More...
CEVEC Pharma Release: Completion of a "First in Human" Clinical Phase I Study With a Therapeutic Protein Derived From CAP® Cells 11/1/2013  More...
New Two-Hormone Roche (RHHBY) Drug Shows Promise in Diabetes, Obesity 11/1/2013  More...
Kamada Ltd. (KMDA.TA) Reports New Data From an Extension Study of Its Phase I/II Trial With Glassia in Pediatric Patients With Type 1 Diabetes 10/31/2013  More...
ISA Pharmaceuticals Initiates Phase I/II Clinical Trial With ISA101 in Women With Cervical Cancer 10/29/2013  More...
Clovis Oncology (CLVS)'s CO-1686 Continues to Demonstrate Promising Clinical Activity and Safety in Updated Phase I Study Results 10/28/2013  More...
Immunicum Doses the First Patient in a New Clinical Phase I/II-Study in Primary Liver Cancer 10/23/2013  More...
Galapagos NV (GLPG.BR) Presents Superior Potentiator Series for CF 10/17/2013  More...
Oxford BioMedica PLC (OXB.L) Receives Agreement From FDA and ANSM to Resume Recruitment Into Ocular Clinical Trials 10/17/2013  More...
Galapagos NV (GLPG.BR) to Present Phase 1 Data on FFA2 Antagonist GLPG0974 at UEG Week in Berlin 10/16/2013  More...
Protalix Biotherapeutics, Inc. (PLX) Announces Positive Phase I Clinical Trial Results for Oral GCD in Gaucher Disease Patients 10/14/2013  More...
Sihuan Pharmaceutical Holdings Group Ltd. Approved for China Trials of Innovative Cancer Drug 10/11/2013  More...
Karolinska Development AB: Pergamum Announces Final Data From Phase I/II Study of LL-37 in Patients With Chronic Leg Ulcers 10/10/2013  More...
Medivir AB (MVIRb.F) Release: Positive Results From a Phase I Study With MIV-711 for the Treatment of Osteoarthritis and Other Bone Related Disorders 10/9/2013  More...
Scancell Release: Investor Update Showcases Moditope® Platform and Updates SCIB1 Trial Progress 10/1/2013  More...
Tesaro, Inc. Describes Initial Phase 1 Clinical Data for TSR-011 Presented at the European Cancer Congress 2013 9/30/2013  More...
BerGenBio AS Study Published in Blood Highlights Axl Inhibition as a Novel Therapeutic Approach for Acute Myeloid Leukemia 9/30/2013  More...
Ariad Pharmaceuticals, Inc. (ARIA) Presents Updated Phase 1/2 Data on AP26113 in Patients With Non-Small Cell Lung Cancer 9/30/2013  More...
To-BBB technologies BV Presents Clinical Data on Lead Product 2B3-101 9/26/2013  More...
Living Cell Technologies Ltd. Release: First-in-Man' Implant of Regenerative Cell Therapy in Parkinson's Disease 9/24/2013  More...
Versartis, Inc. Presents Latest Positive Results From Its Pediatric Study of Long-Acting Growth Hormone Treatment at International Endocrinology Conference 9/23/2013  More...
Skyepharma PLC (SKYEF) Release: Flutiform Trial for COPD Initiated in Europe 9/19/2013  More...
ISA Pharmaceuticals Initiates Phase I/II Clinical Trial of ISA101 in Patients With Anal Intraepithelial Neoplasia (AIN) 9/16/2013  More...
Wanbang Biopharmaceuticals to Begin Clinical Trial of Fast-Acting Insulin Analogue 9/16/2013  More...
Patrys Limited (PAB.AX) Release: PAT-SM6 Receives Orphan Drug Designation for Multiple Myeloma in Europe 9/12/2013  More...
Dompe Announces the FDA Has Granted Orphan Drug Designation to Its rhNGF-Based Treatment for Retinitis Pigmentosa 9/11/2013  More...
Anergis Reports Positive Phase IIb Data for Birch Pollen Allergy Vaccine AllerT 9/10/2013  More...
Arno Therapeutics Submits IMPD to French Health Authority to Initiate Phase I Trial of Onapristone in PR Positive Tumors 9/9/2013  More...
Gamida Cell Ltd. Announces the Successful Transplantation of the First Patient in the Company's Phase I/II Study of NiCord® in a Single Cord Configuration 9/9/2013  More...
ProSensa Holding N.V. Initiates First Patient Dosing in Phase I/II trial of PRO053 9/6/2013  More...
Hua Medicine Begins Phase I Trial of Novel Diabetes Treatment 9/6/2013  More...
Apitope Announces Positive Results From Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis 9/3/2013  More...
Imaxio Announces the First Human Clinical Trial Using Its Pro-Immunogenic Technology IMX313 in Tuberculosis 9/3/2013  More...
Congenia Announces Enrollment of First Healthy Volunteer in Phase 1 Clinical Trial of GNX-5086 8/27/2013  More...
Karolinska Development AB: Lipidor Reports Positive Clinical Phase I/II Data in Psoriasis 8/27/2013  More...
Lipidor Reports Positive Clinical Phase I/II Data in Psoriasis 8/27/2013  More...
Oncolytic Virus Specialist Virttu Biologics Confirms Treatment of First Cohort of Patients in Phase I/II SEPREHVIR® Study in Mesothelioma 8/26/2013  More...
Patrys Limited (PAB.AX) Release: Data From 2nd and 3rd Cohorts of Patients in Multiple Myeloma Clinical Trial 8/13/2013  More...
Trophos Completes Patient Enrolment in a First Study of Olesoxime in Relapsing Remitting Multiple Sclerosis 8/7/2013  More...
Patrys Limited (PAB.AX)'s Multiple Myeloma Clinical Trial to Progress to Final Patient Group 8/7/2013  More...
AllaChem Announces the Beginning of Phase I Clinical Studies of AV4025, a Potent Small Molecule for the Treatment of Chronic Hepatitis C Infection 8/5/2013  More...
Boehringer Ingelheim Corporation Release: First Patient Enrolled in New Cardiovascular and Renal Outcomes Trial for linagliptin in Type 2 Diabetes 7/31/2013  More...
uniQure Announces Start of Parkinson's Disease Gene Therapy Phase I Trial by University of California, San Francisco (UCSF)/National Institutes of Health (NIH) to Test Its GDNF Gene in Patients 7/29/2013  More...
PRANA Biotechnology (PRAN) Doses First Patient in PBT2 Alzheimer's Extension Study 7/29/2013  More...
Patrys Limited (PAB.AX) Completes Treatment of Third Patient Group in Multiple Myeloma Trial 7/25/2013  More...
Adaptimmune Ltd. Announces Opening of Phase I/IIa Clinical Trial in Ovarian Cancer 7/25/2013  More...
Immunicum AB Release: The Medical Products Agency Clears Unique Swedish Cancer Vaccine for Clinical Tests in Liver Cancer Patients 7/22/2013  More...
TopoTarget A/S Release: Belinostat Gets European Orphan Drug Designation for the Treatment of Malignant Thymomas 7/18/2013  More...
Alize Pharma Launches the First Phase I Clinical Trial for AZP-531, Its Unacylated Ghrelin Analog, in Type 2 Diabetes 7/16/2013  More...
Probiodrug AG Provides Update on Clinical Development of PQ912, Its Most Advanced QC-Inhibitor for Alzheimer's Disease 7/16/2013  More...
Vernalis PLC (VNLPY.PK) Initiates Phase Ib/II POC Study of V81444 7/12/2013  More...
Scancell SCIB1 8mg Study Update 7/12/2013  More...
Pluristem Therapeutics (PSTI) Completes Enrollment for Phase I/II Muscle Injury Trial 7/11/2013  More...
Ablynx Starts Additional Phase I Studies With Anti-RSV Nanobody ALX-0171 7/8/2013  More...
Immunomedics, Inc. (IMMU) Reports First Results From Phase Ib Study of 90Y-Clivatuzumab in Patients With Metastatic Pancreatic Cancer After 2 or More Prior Therapies 7/3/2013  More...
CLL Pharma and Leurquin-Mediolanum Announce Initiation of Phase 1b Clinical Trial of the Compound Syn1002 in Pain 7/2/2013  More...
GlaxoSmithKline (GSK) Muscular Dystrophy Drug Gets "Breakthrough" Status 6/28/2013  More...
Edge Therapeutics Reports Positive Early Clinical Experience With EG-1962 to Prevent Serious Complications After Brain Hemorrhage 6/27/2013  More...
Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Publication Elucidates Novel miR-34 Tumor Suppressor Pathway, Underscores miR-34 as Important Anticancer Approach 6/26/2013  More...
Verona Pharma Release: First Patient Dosed in Clinical Trial to Further Evaluate Efficacy of VRP700 as a Treatment for Chronic Severe Cough 6/24/2013  More...
Affimed Therapeutics AG Reports Phase 1 Clinical Data for Its Immunotherapy AFM13 in Relapsing/Refractory Hodgkin Lymphoma Patients 6/24/2013  More...
Ablynx' Partner Initiates a Phase I Study and Doses First Healthy Volunteer With ALX-0761 6/21/2013  More...
BerGenBio AS Announces Initiation of Phase I Clinical Trial for First-in-Class AXL Receptor Tyrosine Kinase Inhibitor BGB324 to Treat Aggressive and Metastatic Cancers 6/20/2013  More...
Allied's Herpes Vaccine Progresses to Phase 1 Clinical Trial 6/19/2013  More...
Vaxil Reports Promising Results From Its Follow-Up Clinical Trial of ImMucin in Multiple Myeloma a Patients 6/18/2013  More...
As the First Biopharmaceutical Company Worldwide, Apceth GmbH Receives Approval for a Clinical Trial With Genetically Modified Adult Mesenchymal Stem Cells for the Treatment of Cancer 6/13/2013  More...
Nanobiotix Receives Approval From ANSM to Start New Clinical Trial With Lead Product NBTXR3 6/13/2013  More...
Imperial Innovations Release: Autifony Initiates Phase I Trial for Treatment of Hearing Loss and Tinnitus 6/4/2013  More...
Nanobiotix' NBTXR3 Achieves Clinical Milestone Reaching Proof-Of-Concept in Phase I Trial of Soft Tissue Sarcoma 6/3/2013  More...
VBL Therapeutics Release: Phase I/II Data of VB-111 Demonstrate Anti-Tumor Effects With Increase in Overall Survival With This Anti-Angiogenic Gene Therapy, in Patients With Recurrent Glioblastoma Multiforme 6/3/2013  More...
TopoTarget A/S Release: Positive Data From the BELIEF trial presented at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013  More...
VBL Therapeutics Release: Phase I/II Data of VB-111 Demonstrate Anti-Tumor Effects With Increase in Overall Survival with This Anti-Angiogenic Gene Therapy, in Patients With Recurrent Glioblastoma Multiforme 6/3/2013  More...
Virttu Biologics U.S. Phase I Pediatric Study is Extended to Include Systemic Delivery of Oncolytic Virus 5/31/2013  More...
Ferring Pharmaceuticals Presents Phase III Data for a Controlled Release Misoprostol Vaginal Delivery System for Labour Induction at the First European Congress on Intrapartum Care 5/28/2013  More...
First Patient Dosed in the Phase I/II Study of Umecrine Mood’s Candidate Drug for Premenstrual Dysphoric Disorder 5/23/2013  More...
Medivir AB (MVIRb.F) Release: Positive Results From a Phase Ia Study With MIV-711 for the Treatment of Skeletal Disorders 5/21/2013  More...
Addex Therapeutics (ADXN.SW) Validates Potential Efficacy Biomarker for Phase 1 Trial of Its GABA-B Positive Allosteric Modulator, ADX71441 5/21/2013  More...
Immunicum AB Release: Promising Data for Cancer Vaccine INTUVAX™ in the Treatment of Kidney Cancer 5/20/2013  More...
R-Tech Ueno: Start of the Patient Enrollment of a Phase I/II Clinical Study of Recombinant Human Serum Albumin-Containing Ophthalmic Solution (Development Code: RU-101) in U.S. for the Treatment of Severe Dry Eye 5/20/2013  More...
A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing 5/17/2013  More...
Successful Phase One Demonstrates Tumor Response With Increased Overall Survival for Lead VBL Therapeutics Compound in Cancer 5/16/2013  More...
Theravalues Release: A Clinical Study Shows the Theracurmin®'s Safety and Potential Role in Improving Quality of Life (QOL) of Pancreatic Cancer Patients 5/10/2013  More...
Patrys Limited (PAB.AX) Release: PAT-SM6 Kills Human Multiple Myeloma Cells 5/8/2013  More...
Imperial Innovations' Cell Medica Treats First Paediatricpatient in Clinical Trial of Cytovir ADV 5/8/2013  More...
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Third Patient Group 4/24/2013  More...
Addex Therapeutics (ADXN.SW) Receives Approval to Initiate a Phase 1, First-In-Man, Clinical Study for ADX71441 4/24/2013  More...
Patrys Limited (PAB.AX) Release: New Data Strengthens PAT-SM6 Profile as an Anti-Cancer Treatment 4/22/2013  More...
Karolinska Development AB: Pergamum Announces Last Visit of Last Patient in a Phase I/II Trial of a Potential New Treatment for Hard-to-Heal Wounds 4/19/2013  More...
BioInvent (BOVNF) Release: Preclinical Data Published in Cancer Cell Highlight Novel Antibody BI-505 and Potent Anti-Myeloma Activity 4/16/2013  More...
Genentech (RHHBY)'s Immune Therapy Cancer Drug Shows Promise in Early Study 4/12/2013  More...
Patrys Limited (PAB.AX) Completes Treatment of Second Patient Group in Multiple Myeloma Trial 4/10/2013  More...
SAGE Therapeutics' Refractory Status Epilepticus Program Demonstrates Efficacy in First-in-Man Experience; Case Study to be Highlighted at International SE Meeting 4/4/2013  More...
Protalix Biotherapeutics, Inc. (PLX) Treats First Gaucher Patient in Phase I Study With PRX-112, an Orally-Administered Enzyme Treatment of Gaucher Disease 4/2/2013  More...
Agenix Limited to File for Clinical Trial of Hepatitis B Drug by June 4/1/2013  More...
Curie-Cancer Trebles Number of Early Phase Clinical Research Studies With Industry Partners 3/26/2013  More...
Daval International Limited CSO Presents Results From an Exploratory Clinical Trial of AIMSPRO in Amyotrophic Lateral Sclerosis (ALS) at American Academy of Neurology Annual Meeting 3/21/2013  More...
Vince & Associates Clinical Research Sponsors the 14th Annual Phase I & IIa Clinical Trials Conference in London 3/19/2013  More...
Scancell Welcomes New Study in The Journal of Clinical Investigation Suggesting That Melanoma Switches Off the Immune System 3/14/2013  More...
BrainStorm Cell Therapeutics Inc. Presents Breakthrough Phase I/II ALS Clinical Data at the American Academy of Neurology Annual Meeting 3/13/2013  More...
Patrys Limited (PAB.AX) Release: Data From 1st Cohort of Patients in Multiple Myeloma Clinical Trial 3/7/2013  More...
InnaVirVax Announces Presentation of the Results of Its Phase I/IIa Clinical Study at CROI 2013 in Atlanta 3/5/2013  More...
Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080 3/4/2013  More...
Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Hail Results of Dermatitis Study 3/4/2013  More...
PROMETHERA Biosciences S.A./N.V. Opens the French Part of Its Clinical Trial in Cell Therapy 2/28/2013  More...
Quinten Identifies a Combination of Two Synergistic Markers That Predicts a Favorable Response to Treatment in Triple-Negative Breast Cancer 2/25/2013  More...
Gamida Cell Ltd.'s NiCord® Demonstrates Successful Engraftment in Patients With Hematological Malignancies in Phase I/II Study 2/15/2013  More...
Clasado Announces Positive Results of Clinical Study of Bimuno® for Metabolic Syndrome 2/15/2013  More...
Dompe Release: The First Patient Has Been Enrolled in the First International Clinical Trial of rhNGF for the Treatment of Neurotrophic Keratitis 2/14/2013  More...
VAXIMM Study Meets Endpoints in Phase 1/2 2/7/2013  More...
Genethon Receives Approval From the UK Medicine Regulatory Agency to Start a New Clinical Trial for an Inherited Immune Deficiency: Chronic Granulomatous Disease 2/5/2013  More...
OncoEthix Doses First Patient in Its Phase I Trial of OTX015, a BET Bromodomain Inhibitor for the Treatment of Hematologic Malignancies 1/31/2013  More...
Medgenics, Inc. Launches First Clinical Trial in Hepatitis to Use INFRADURE Tissue Treatment 1/30/2013  More...
Algeta Initiates New Oncology Research Program to Evaluate the Potential of a Targeted Thorium Conjugate (TTC) Based on Immunomedics, Inc. (IMMU)'s Anti-CD22 Monoclonal Antibody 1/28/2013  More...
BioInvent (BOVNF): Positive Results From the BI-505 Phase I Study in Multiple Myeloma 1/24/2013  More...
Molecular Partners AG Announces Publication of Results From a Phase I/II Clinical Trial of Its anti-VEGF DARPin MP0112 in Diabetic Macular Edema 1/17/2013  More...
Patrys Limited (PAB.AX) Progresses Multiple Myeloma Clinical Trial to Second Patient Group 1/15/2013  More...
Proteo, Inc. / Proteo Biotech AG: FDA Grants Proteo Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension 1/10/2013  More...
Merus Selects Clinical Candidate for the Treatment of Acute Myeloid Leukemia (AML) 1/7/2013  More...
Aspireo Pharmaceuticals Reports Somatoprim Phase I b Interim Data 1/7/2013  More...
Alkermes plc (ALKS) Expands CNS Pipeline and Announces Positive Results From Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia 1/3/2013  More...
Kareus Therapeutics Announces Phase I Trial for Product in Alzheimer's Disease 1/3/2013  More...
Ironwood Pharmaceuticals Begins Phase I Trial of Investigational IW-2143 Anxiety Drug in US 12/21/2012  More...
Innate Pharma (IPH.PA ): Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced 12/19/2012  More...
Boston Therapeutics, Inc. Approved in France to Initiate a Clinical Trial With SUGARDOWN® in Patients With Type II Diabetes 12/19/2012  More...
e-Therapeutics plc Provides Update on Progress of ETS2101 Cancer Trials 12/18/2012  More...
Innate Pharma (IPH.PA ) (Euronext Paris: FR0010331421 - IPH): First Patient Treated in the EffiKIR Trial 12/17/2012  More...
PDC Biotech GmbH Announces Successful Clinical Phase I for Its Lead Compound PDC31 12/13/2012  More...
Hepatera Release: Maxwell Biotech Venture Fund’s Portfolio Company Hepatera Recruits First Patients in Phase 1b/2a Clinical Trial of Myrcludex B for HBV 12/12/2012  More...
Patrys Limited (PATZF.PK) Completes Treatment of First Patient Group in Multiple Myeloma Trial 12/10/2012  More...
Cancer Vaccine Specialist Scancell's SCIB1 Phase 1/2 Clinical Trial Reports Preliminary Evidence of Immune Response and Clinical Benefit 12/6/2012  More...
THERAVECTYS is Granted Authorization From the French and Belgian Regulatory Agencies to Launch a Phase I/Ii Clinical Trial for Its Anti-HIV Therapeutic Vaccine Candidate 11/30/2012  More...
InnaVirVax: the Phase I/IIa Clinical Study of Its VAC-3S Immunotherapeutic Vaccine in the Treatment of HIV Infection Has Achieved Its Primary Endpoint 11/30/2012  More...
NovImmune SA Initiates Phase I Clinical Study With First-in-Class Anti-TLR4 Monoclonal Antibody 11/28/2012  More...
Apitope Completes Recruitment Into Its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis 11/26/2012  More...
Basilea Pharmaceutica (BSLN.SW) Initiates Next Phase 1 Multiple Ascending Dose Study With Antibiotic Bal30072 Active Against Multidrug-Resistant Gram-Negative Bacteria 11/26/2012  More...
Ethical Approval for Living Cell Technologies Ltd.'s NTCELL® Phase I Trial 11/16/2012  More...
Pluristem Therapeutics (PSTI) to Initiate a Phase I/II Clinical Trial in Muscle Injury 11/14/2012  More...
Nanobiotix: Phase I Independent Data Monitoring Committee Confirms Good Safety of NBTXR3 in the First Group of Patients With Advanced Soft Tissue Sarcoma 11/13/2012  More...
CellAct Pharma's Topoisomerase Inhibitor Demonstrates Success in Phase I Study Involving Adults With Heavily Pretreated Solid Tumors 11/12/2012  More...
MorphoSys AG Reports Successful Phase 1 Study of MOR103 Using a Subcutaneous Administration 11/12/2012  More...
Pluristem Therapeutics (PSTI) Reveals Second Patient Death 11/9/2012  More...
Girl Dies as Pluristem Therapeutics (PSTI) Sells on Gains With Miracle Cells 11/9/2012  More...
Lophius Biosciences GmbH Achieves First Clinical Proof of Principle for T-Track® TB for Detection of Active Tuberculosis and Receives Research Funding 11/8/2012  More...
Senz Oncology Initiates VAL-1000 Clinical Trial in Patients With Acute Leukemias 11/7/2012  More...
Patrys Limited (PATZF.PK) Enrolls First Patient in Multiple Myeloma Trial 11/7/2012  More...
Summit Corporation Release: Repeat Dosing of SMT C1100 for Treatment of Duchenne Muscular Dystrophy Meets Endpoints in Phase 1 Clinical Trial 11/7/2012  More...





 

//-->